US Markets

Canadian dollar strengthens as vaccine hopes boost global stocks

Credit: REUTERS/MARK BLINCH

The Canadian dollar rose against the greenback on Wednesday as investors grew more optimistic about a COVID-19 vaccine and after the Bank of Canada reinforced its commitment to support economic recovery.

(Adds economist quote and details throughout; updates prices)

* Canadian dollar gains 0.5% against the greenback

* Bank of Canada holds benchmark interest rate at 0.25%

* Canadian manufacturing sales rise 10.7% in May

* Canada-U.S. 10-year spread widens by 1.7 basis points

By Fergal Smith

TORONTO, July 15 (Reuters) - The Canadian dollar rose against the greenback on Wednesday as investors grew more optimistic about a COVID-19 vaccine and after the Bank of Canada reinforced its commitment to support economic recovery.

Canada's economic growth will not return to pre-pandemic levels until 2022, the Bank of Canada said, in an outlook that was cautious on U.S. growth. It left its benchmark interest rate at 0.25%, a level it considers to be the floor, and said it would remain at that level until economic slack is absorbed.

"The BoC remains all-in in terms of its commitment to stimulus in order to support the recovery of the economy," said Ryan Brecht, a senior economist at Action Economics.

World shares climbed toward a four-month high after U.S. researchers reported that Moderna Inc's experimental vaccine for COVID-19 showed it was safe in an ongoing early-stage study.

Canada runs a current account deficit and is a major exporter of commodities, including oil, so the loonie tends to be sensitive to the global flow of trade and capital.

U.S. crude prices were up 1% at $40.70 a barrel after a sharp drop in U.S. crude inventories.

The Canadian dollar was trading 0.5% higher at 1.3546 to the greenback, or 73.82 U.S. cents. The currency, which on Tuesday touched its weakest intraday level since June 30 at 1.3646, traded in a range of 1.3543 to 1.3617.

Canadian factory sales jumped by a record 10.7% in May from April as many manufacturers resumed operations following partial shutdowns related to the coronavirus outbreak, Statistics Canada said. Analysts in a Reuters poll had forecast a gain of 9.5% in May.

Canada's 10-year was nearly unchanged at 0.537%, while it traded 1.7 basis points further below the U.S. 10-year yield for a spread of 9.5 basis points. (Reporting by Fergal Smith Editing by Nick Zieminski and Steve Orlofsky) ((fergal.smith@thomsonreuters.com; +1 416 941 8113;)) Keywords: CANADA FOREX/ (UPDATE 1)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More